PGP and neoplasm: The 2,4,5-trimethoxybenzanilide derivative 1, which proved to be a potent P-glycoprotein (P-gp) inhibitor [6], was taken as the hit compound for an optimization study aimed at disclosing new chemical entities active toward P-gp-mediated multidrug resistant tumor cells.